Pfizer Moving Antibacterial R&D from US to Shanghai
March 16, 2011 at 06:23 AM EDT
Pfizer will close its R&D facility in Groton, Connecticut and move its antibacterials research operations to Shanghai. Although all major multinationals are doing research in China, it is highly unusual for a big pharma to move an entire lab there. More details.... Stock Symbol: (NYSE: PFE) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});